198 related articles for article (PubMed ID: 19933496)
1. Decreased C-reactive protein levels in Alzheimer disease.
O'Bryant SE; Waring SC; Hobson V; Hall JR; Moore CB; Bottiglieri T; Massman P; Diaz-Arrastia R
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):49-53. PubMed ID: 19933496
[TBL] [Abstract][Full Text] [Related]
2. The link between C-reactive protein and Alzheimer's disease among Mexican Americans.
O'Bryant SE; Johnson L; Edwards M; Soares H; Devous MD; Ross S; Rohlfing G; Hall J;
J Alzheimers Dis; 2013; 34(3):701-6. PubMed ID: 23254637
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid, homocysteine and CRP: potential markers for dementia.
Davis G; Baboolal N; Nayak S; McRae A
Neurosci Lett; 2009 Nov; 465(3):282-4. PubMed ID: 19766699
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
5. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia.
Hazen J; Vistnes M; Barca ML; Eldholm RS; Persson K; Brækhus A; Saltvedt I; Selbæk G; Engedal K; Knapskog AB
Alzheimer Dis Assoc Disord; 2020; 34(1):47-53. PubMed ID: 31414991
[TBL] [Abstract][Full Text] [Related]
7. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
[TBL] [Abstract][Full Text] [Related]
8. A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer's Disease.
Gong C; Wei D; Wang Y; Ma J; Yuan C; Zhang W; Yu G; Zhao Y
Am J Alzheimers Dis Other Demen; 2016 May; 31(3):194-200. PubMed ID: 26340961
[TBL] [Abstract][Full Text] [Related]
9. Effect of Alzheimer caregiving on circulating levels of C-reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study.
von Känel R; Mills PJ; Mausbach BT; Dimsdale JE; Patterson TL; Ziegler MG; Ancoli-Israel S; Allison M; Chattillion EA; Grant I
Gerontology; 2012; 58(4):354-65. PubMed ID: 22133914
[TBL] [Abstract][Full Text] [Related]
10. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
[TBL] [Abstract][Full Text] [Related]
11. Is there a relationship between high C-reactive protein (CRP) levels and dementia?
Mancinella A; Mancinella M; Carpinteri G; Bellomo A; Fossati C; Gianturco V; Iori A; Ettorre E; Troisi G; Marigliano V
Arch Gerontol Geriatr; 2009; 49 Suppl 1():185-94. PubMed ID: 19836632
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory markers in Alzheimer's disease and vascular dementia].
Androsova LV; Mikhaĭlova NM; Zozulia SA; Dupin AM; Rassadina GA; Lavrent'eva NV; Kliushnik TP
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):49-53. PubMed ID: 23528583
[TBL] [Abstract][Full Text] [Related]
13. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
[TBL] [Abstract][Full Text] [Related]
14. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old.
Kravitz BA; Corrada MM; Kawas CH
Alzheimers Dement; 2009 Jul; 5(4):318-23. PubMed ID: 19560102
[TBL] [Abstract][Full Text] [Related]
15. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
O'Bryant SE; Waring SC; Cullum CM; Hall J; Lacritz L; Massman PJ; Lupo PJ; Reisch JS; Doody R;
Arch Neurol; 2008 Aug; 65(8):1091-5. PubMed ID: 18695059
[TBL] [Abstract][Full Text] [Related]
16. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease.
Yarchoan M; Louneva N; Xie SX; Swenson FJ; Hu W; Soares H; Trojanowski JQ; Lee VM; Kling MA; Shaw LM; Chen-Plotkin A; Wolk DA; Arnold SE
J Neurol Sci; 2013 Oct; 333(1-2):9-12. PubMed ID: 23978419
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers for dementia in Trinidad and Tobago.
Davis GK; Baboolal NS; Seales D; Ramchandani J; McKell S; McRae A
Neurosci Lett; 2007 Aug; 424(1):27-30. PubMed ID: 17703882
[TBL] [Abstract][Full Text] [Related]
18. Combination of clinical and neuropsychologic information as a better predictor of the progression to Alzheimer disease in questionable dementia individuals.
Lee DY; Youn JC; Choo IH; Kim KW; Jhoo JH; Pak YS; Suh KW; Woo JI
Am J Geriatr Psychiatry; 2006 Feb; 14(2):130-8. PubMed ID: 16473977
[TBL] [Abstract][Full Text] [Related]
19. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time.
Nilsson K; Gustafson L; Hultberg B
Clin Biochem; 2011 Oct; 44(14-15):1205-8. PubMed ID: 21819975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
